EyeFair enuff attitude on your part, but I expect their motive to be job preservation, rather than purchasing more shares in a good investment. Brett never sits in the queue for cheap shares, from my observations. I expect that it is him at 2.7.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025